Jun Bai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jun Bai has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
- Qingbi Zhang
Environmental Health Effects and Risk Assessment Key Laboratory of Luzhou, School of Public Health, Southwest Medical University, Luzhou 646000, Sichuan, PR China
4 shared publications Yingyi Liu
Environmental Health Effects and Risk Assessment Key Laboratory of Luzhou, School of Public Health, Southwest Medical University, Luzhou, 646000, China
4 shared publicationsChenwen Li
Environmental Health Effects and Risk Assessment Key Laboratory of Luzhou, School of Public Health, Southwest Medical University, Luzhou, China
3 shared publicationsLei Chen
Environmental Health Effects and Risk Assessment Key Laboratory of Luzhou, School of Public Health
3 shared publicationsLi Liu
Skin Structure and Function Key Laboratory of Luzhou, Department of Dermatology
3 shared publicationsSimei Yang
Environmental Health Effects and Risk Assessment Key Laboratory of Luzhou, School of Public Health
3 shared publications
Latest Publications
- 19 June 2026
- Published by Wiley in Journal of Applied Toxicology
Cigarette Smoke Promotes Lung Cancer Progression by Mediating EMT Through the IL‐9‐Regulated STAT3/miR‐155‐5p/SOCS1 Feedback Loop
Lung cancer is among the most common malignancies globally, exhibiting the greatest rates of incidence and death compared to all other cancers. Cigarette smoking is a significant causal factor in lung cancer; yet the molecular mechanisms via which smoking facilitates lung cancer development remain mainly ambiguous. In this study, we used different concentrations of cigarette smoke extract (CSE) to A549 cells. Compared with the control group, the total STAT3 expression remained basically unchanged. However, we found that phosphorylated STAT3 (p‐STAT3), interleukin‐9 (IL‐9), and miR‐155‐5p all increased obviously, while the expression of suppressor of cytokine signaling 1 (SOCS1) decreased greatly. Moreover, the epithelial marker E‐cadherin was downregulated, while the mesenchymal markers Vimentin and α‐SMA were upregulated, indicating the induction of epithelial‐mesenchymal transition (EMT). Interventions with STAT3 siRNA, a miR‐155‐5p inhibitor, or a SOCS1 overexpression plasmid reversed these changes. Similarly, co‐treatment with an IL‐9‐neutralizing antibody attenuated CSE‐induced alterations in p‐STAT3, SOCS1, miR‐155‐5p, and EMT markers. In a nude mouse xenograft model, CSE exposure significantly enhanced tumor growth and EMT phenotypes, whereas IL‐9 neutralization reduced tumorigenicity of CSE‐treated A549 cells. Collectively, these findings demonstrate that cigarette smoke promotes lung cancer progression by inducing EMT through the IL‐9‐regulated STAT3/miR‐155‐5p/SOCS1 feedback loop, providing novel mechanistic insight and potential therapeutic targets for smoking‐related lung cancer.
- 19 June 2026
- Published by Wiley in Journal of Applied Toxicology
Cigarette Smoke Promotes Lung Cancer Progression by Mediating EMT Through the IL‐9‐Regulated STAT3/miR‐155‐5p/SOCS1 Feedback Loop
Lung cancer is among the most common malignancies globally, exhibiting the greatest rates of incidence and death compared to all other cancers. Cigarette smoking is a significant causal factor in lung cancer; yet the molecular mechanisms via which smoking facilitates lung cancer development remain mainly ambiguous. In this study, we used different concentrations of cigarette smoke extract (CSE) to A549 cells. Compared with the control group, the total STAT3 expression remained basically unchanged. However, we found that phosphorylated STAT3 (p‐STAT3), interleukin‐9 (IL‐9), and miR‐155‐5p all increased obviously, while the expression of suppressor of cytokine signaling 1 (SOCS1) decreased greatly. Moreover, the epithelial marker E‐cadherin was downregulated, while the mesenchymal markers Vimentin and α‐SMA were upregulated, indicating the induction of epithelial‐mesenchymal transition (EMT). Interventions with STAT3 siRNA, a miR‐155‐5p inhibitor, or a SOCS1 overexpression plasmid reversed these changes. Similarly, co‐treatment with an IL‐9‐neutralizing antibody attenuated CSE‐induced alterations in p‐STAT3, SOCS1, miR‐155‐5p, and EMT markers. In a nude mouse xenograft model, CSE exposure significantly enhanced tumor growth and EMT phenotypes, whereas IL‐9 neutralization reduced tumorigenicity of CSE‐treated A549 cells. Collectively, these findings demonstrate that cigarette smoke promotes lung cancer progression by inducing EMT through the IL‐9‐regulated STAT3/miR‐155‐5p/SOCS1 feedback loop, providing novel mechanistic insight and potential therapeutic targets for smoking‐related lung cancer.
- 10 February 2026
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 69 (4) , 4579-4601
Natural Product–Inspired PROTACs for Leukemia Therapy: Hederagenin-Driven Targeted Degradation of SKP2
Leukemia is a malignant neoplasm originating from the hematopoietic system. T-cell acute lymphoblastic leukemia (T-ALL) represents a typical subtype, posing a particularly serious threat to children. Hederagenin (HED) is a natural product with broad-spectrum antitumor potential, yet its activity remains insufficient and requires optimization. Here, we employed PROTAC technology to design and synthesize a series of HED derivatives. Among them, HD15 demonstrated optimal activity in Jurkat cells (IC50 = 0.98 μM), significantly outperforming the parent compound HED (IC50 > 40 μM), and effectively inhibited xenograft tumor growth. Mechanistically, HD15 effectively degraded SKP2 (DC50 = 0.29 μM), stabilizing SOCS1 expression and modulating immunoproteasome expression via the JAK/STAT pathway, thereby suppressing tumor cell proliferation. The discovery of HD15 demonstrates the promise of PROTAC technology in enhancing the efficacy of natural products and identifying therapeutic targets, offering a novel strategy for developing therapeutics from natural products.
- 10 February 2026
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 69 (4) , 4579-4601
Natural Product–Inspired PROTACs for Leukemia Therapy: Hederagenin-Driven Targeted Degradation of SKP2
Leukemia is a malignant neoplasm originating from the hematopoietic system. T-cell acute lymphoblastic leukemia (T-ALL) represents a typical subtype, posing a particularly serious threat to children. Hederagenin (HED) is a natural product with broad-spectrum antitumor potential, yet its activity remains insufficient and requires optimization. Here, we employed PROTAC technology to design and synthesize a series of HED derivatives. Among them, HD15 demonstrated optimal activity in Jurkat cells (IC50 = 0.98 μM), significantly outperforming the parent compound HED (IC50 > 40 μM), and effectively inhibited xenograft tumor growth. Mechanistically, HD15 effectively degraded SKP2 (DC50 = 0.29 μM), stabilizing SOCS1 expression and modulating immunoproteasome expression via the JAK/STAT pathway, thereby suppressing tumor cell proliferation. The discovery of HD15 demonstrates the promise of PROTAC technology in enhancing the efficacy of natural products and identifying therapeutic targets, offering a novel strategy for developing therapeutics from natural products.
- 29 December 2025
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
Dual-Modal Therapeutic Nanoplatform: Harnessing Caspase-1/GSDMD Pyroptosis and Photothermal Effects for Tumor Treatment
Currently, most cancer treatment strategies focus on surgical resection of malignant tumors, complemented by physicochemical therapies such as radiotherapy and chemotherapy. However, these approaches are plagued by critical limitations, including suppression of normal cell growth and severe systemic toxicity-related side effects. In recent years, novel cancer therapeutic modalities, particularly photothermal therapy (PTT), have arisen potentially viable alternatives to tumor therapy, because of their minimal side effects, precise controllability, and superior selectivity. This research is designed to develop an integrated antitumor, NIR-II-responsive nanoparticle, and to investigate its therapeutic potential through efficacy assessment in both cellular and animal models, along with mechanistic studies. Specifically, we engineered a hybrid nanosystem by incorporating the NIR-II fluorescent dye IR817 into the zeolitic imidazolate framework ZIF-8. This design strategy significantly enhances the IR817 photothermal conversion efficiency and bolsters the overall photothermal therapeutic efficacy. Notably, the dual functionality of ZIF-8 as both a nanocarrier and a pyroptosis inducer, combined with the photothermal effect of IR817, thereby provides improved overall antitumor outcomes.
- 29 December 2025
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
Dual-Modal Therapeutic Nanoplatform: Harnessing Caspase-1/GSDMD Pyroptosis and Photothermal Effects for Tumor Treatment
Currently, most cancer treatment strategies focus on surgical resection of malignant tumors, complemented by physicochemical therapies such as radiotherapy and chemotherapy. However, these approaches are plagued by critical limitations, including suppression of normal cell growth and severe systemic toxicity-related side effects. In recent years, novel cancer therapeutic modalities, particularly photothermal therapy (PTT), have arisen potentially viable alternatives to tumor therapy, because of their minimal side effects, precise controllability, and superior selectivity. This research is designed to develop an integrated antitumor, NIR-II-responsive nanoparticle, and to investigate its therapeutic potential through efficacy assessment in both cellular and animal models, along with mechanistic studies. Specifically, we engineered a hybrid nanosystem by incorporating the NIR-II fluorescent dye IR817 into the zeolitic imidazolate framework ZIF-8. This design strategy significantly enhances the IR817 photothermal conversion efficiency and bolsters the overall photothermal therapeutic efficacy. Notably, the dual functionality of ZIF-8 as both a nanocarrier and a pyroptosis inducer, combined with the photothermal effect of IR817, thereby provides improved overall antitumor outcomes.
- Open Access
- 21 November 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 41345
Exploring the potential mechanisms of anti-pulmonary fibrosis effects of Luo Han Guo via network pharmacology, molecular docking, and experimental validation
Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial lung condition distinguished by a complex etiology, poor prognosis and exhibiting high mortality rates. While therapeutic drugs are currently available, they often come with notable side effects. Luo Han Guo (LHG), a medicinal plant, is known for its properties in moistening the lungs, relieving cough, calming asthma, and resolving phlegm; however, systematic research on its potential therapeutic mechanisms and active ingredients for IPF is lacking. This study utilized network pharmacology to predict the active ingredients, key targets, and potential mechanisms of LHG's anti-IPF effects, followed by molecular docking simulations of the active ingredients and their potential targets, which were subsequently validated through in vivo experiments. From 91 potential targets of LHG, four key targets were identified. Analysis of the compound-target network diagram suggested that kaempferol, 11-oxomogroside V, and Mogrol may be the principal active compounds of LHG for treating IPF. Additionally, KEGG pathway enrichment analysis indicated that LHG might mitigate IPF through the PI3K/AKT and SRC/STAT3 pathways. In conclusion, this study provides preliminary insights into the active constituents and possible molecular mechanisms of LHG in alleviating IPF, offering a novel perspective for investigating the pharmacological effects of LHG in IPF treatment.
- 21 November 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 41345
Open AccessExploring the potential mechanisms of anti-pulmonary fibrosis effects of Luo Han Guo via network pharmacology, molecular docking, and experimental validation
Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial lung condition distinguished by a complex etiology, poor prognosis and exhibiting high mortality rates. While therapeutic drugs are currently available, they often come with notable side effects. Luo Han Guo (LHG), a medicinal plant, is known for its properties in moistening the lungs, relieving cough, calming asthma, and resolving phlegm; however, systematic research on its potential therapeutic mechanisms and active ingredients for IPF is lacking. This study utilized network pharmacology to predict the active ingredients, key targets, and potential mechanisms of LHG's anti-IPF effects, followed by molecular docking simulations of the active ingredients and their potential targets, which were subsequently validated through in vivo experiments. From 91 potential targets of LHG, four key targets were identified. Analysis of the compound-target network diagram suggested that kaempferol, 11-oxomogroside V, and Mogrol may be the principal active compounds of LHG for treating IPF. Additionally, KEGG pathway enrichment analysis indicated that LHG might mitigate IPF through the PI3K/AKT and SRC/STAT3 pathways. In conclusion, this study provides preliminary insights into the active constituents and possible molecular mechanisms of LHG in alleviating IPF, offering a novel perspective for investigating the pharmacological effects of LHG in IPF treatment.
- 15 July 2025
- Published by Wiley in Journal of Applied Toxicology
- Vol. 45 (11) , 2412-2420
FOXA1‐TET1 Mediate the DNA Hypomethylation of IL‐4 Is Involved in Dust Fall PM2.5 Induced Lung Inflammation
PM2.5 has been linked to a variety of lung diseases. The objective of this study was to investigate the mechanism of lung inflammation caused by acute exposure to PM2.5 from the perspective of DNA methylation. Sprague–Dawley male rats were exposed to different concentrations of PM2.5 by non‐exposure intratracheal instillation every other day for 3 times. Chemically modified si‐Foxa1, si‐Tet1, and si‐NC were administered via the intratracheal instillation, followed by exposure to a medium concentration of PM2.5. Fourteen days following the final exposure, serum, bronchoalveolar lavage fluid (BALF), and lung tissues were collected for the appropriate tests. Acute exposure to PM2.5 resulted in infiltration of inflammatory cells and destruction of the alveolar structure. The levels of IL‐4 and eotaxin‐1 in serum and BALF were increased, while the levels of interferon‐γ (IFN‐γ) were decreased. In lung tissues, there was a decrease in the whole genome 5‐mC and an increase in 5‐hmC. The methylation level of the interleukin‐4 (IL‐4) DNA promoter CpG islands decreased, accompanied by an increase in the mRNA level. The protein expression of Forkhead box A1 (FOXA1) and ten‐eleven translocation methylcytosine dioxygenase 1 (TET1) was upregulated. Downregulation of FOXA1 and TET1 levels reversed those changes. PM2.5 induced the upregulation of FOXA1 and TET1 protein expression, which subsequently affected the DNA methylation levels of IL‐4. This, in turn, promoted the release of IL‐4 and led to pulmonary inflammation. This study provides insights into the potential DNA methylation regulatory mechanisms underlying lung inflammation induced by acute PM2.5 exposure.
- 15 July 2025
- Published by Wiley in Journal of Applied Toxicology
- Vol. 45 (11) , 2412-2420
FOXA1‐TET1 Mediate the DNA Hypomethylation of IL‐4 Is Involved in Dust Fall PM2.5 Induced Lung Inflammation
PM2.5 has been linked to a variety of lung diseases. The objective of this study was to investigate the mechanism of lung inflammation caused by acute exposure to PM2.5 from the perspective of DNA methylation. Sprague–Dawley male rats were exposed to different concentrations of PM2.5 by non‐exposure intratracheal instillation every other day for 3 times. Chemically modified si‐Foxa1, si‐Tet1, and si‐NC were administered via the intratracheal instillation, followed by exposure to a medium concentration of PM2.5. Fourteen days following the final exposure, serum, bronchoalveolar lavage fluid (BALF), and lung tissues were collected for the appropriate tests. Acute exposure to PM2.5 resulted in infiltration of inflammatory cells and destruction of the alveolar structure. The levels of IL‐4 and eotaxin‐1 in serum and BALF were increased, while the levels of interferon‐γ (IFN‐γ) were decreased. In lung tissues, there was a decrease in the whole genome 5‐mC and an increase in 5‐hmC. The methylation level of the interleukin‐4 (IL‐4) DNA promoter CpG islands decreased, accompanied by an increase in the mRNA level. The protein expression of Forkhead box A1 (FOXA1) and ten‐eleven translocation methylcytosine dioxygenase 1 (TET1) was upregulated. Downregulation of FOXA1 and TET1 levels reversed those changes. PM2.5 induced the upregulation of FOXA1 and TET1 protein expression, which subsequently affected the DNA methylation levels of IL‐4. This, in turn, promoted the release of IL‐4 and led to pulmonary inflammation. This study provides insights into the potential DNA methylation regulatory mechanisms underlying lung inflammation induced by acute PM2.5 exposure.
- 11 September 2024
- Published by Springer Nature in Archives of Toxicology
- Vol. 98 (12) , 4047-4058
Interleukin-9 promotes EMT-mediated PM2.5-induced pulmonary fibrosis by activating the STAT3 pathway
This study investigated the impact of PM2.5 on promoting EMT in PM2.5-induced pulmonary fibrosis (PF) development and explored molecular mechanisms of the IL-9/STAT3/Snail/TWIST1 signaling pathway in PF owing to PM2.5. Four groups of male SD rats were formed: control (0 mg/kg.bw), low (1 mg/kg.bw), medium (5 mg/kg.bw), and high-dose (25 mg/kg.bw) PM2.5 groups. Experimental rats were subjected to PM2.5 exposure via intratracheal instillation, given once weekly for 16 weeks. 24 h after the final exposure, blood, BALF, and lung tissues were collected. Pulmonary epithelial cells underwent cultivation and exposure to varying PM2.5 concentrations with/without inhibitors for 24 h, after which total protein was extracted for relevant protein assays. The findings demonstrated that PM2.5 damaged lung tissue to different degrees and led to PF in rats. Rats subjected to PM2.5 exposure exhibited elevated concentrations of IL-9 protein in both serum and BALF, and elevated levels of IL-9 and its receptor, IL-9R, in lung tissues, compared to control counterparts. Furthermore, PM2.5-exposed groups demonstrated significantly augmented protein levels of p-STAT3, Snail, TWIST1, Vimentin, COL-I, and α-SMA, while displaying notably diminished levels of E-Cadherin compared to control group. The same findings were observed in PM2.5-treated cells. In BEAS-2B cells co-treated with Stattic (STAT3 inhibitor) and PM2.5, the opposite results occurred. Similar results were obtained for cells co-treated with IL-9-neutralizing antibody and PM2.5. Our findings suggest PM2.5 mediates PF development by promoting IL-9 expression, leading to STAT3 phosphorylation and upregulation of Snail and TWIST1 expression, triggering EMT occurrence and progression in lung epithelial cells.
- 11 September 2024
- Published by Springer Nature in Archives of Toxicology
- Vol. 98 (12) , 4047-4058
Interleukin-9 promotes EMT-mediated PM2.5-induced pulmonary fibrosis by activating the STAT3 pathway
This study investigated the impact of PM2.5 on promoting EMT in PM2.5-induced pulmonary fibrosis (PF) development and explored molecular mechanisms of the IL-9/STAT3/Snail/TWIST1 signaling pathway in PF owing to PM2.5. Four groups of male SD rats were formed: control (0 mg/kg.bw), low (1 mg/kg.bw), medium (5 mg/kg.bw), and high-dose (25 mg/kg.bw) PM2.5 groups. Experimental rats were subjected to PM2.5 exposure via intratracheal instillation, given once weekly for 16 weeks. 24 h after the final exposure, blood, BALF, and lung tissues were collected. Pulmonary epithelial cells underwent cultivation and exposure to varying PM2.5 concentrations with/without inhibitors for 24 h, after which total protein was extracted for relevant protein assays. The findings demonstrated that PM2.5 damaged lung tissue to different degrees and led to PF in rats. Rats subjected to PM2.5 exposure exhibited elevated concentrations of IL-9 protein in both serum and BALF, and elevated levels of IL-9 and its receptor, IL-9R, in lung tissues, compared to control counterparts. Furthermore, PM2.5-exposed groups demonstrated significantly augmented protein levels of p-STAT3, Snail, TWIST1, Vimentin, COL-I, and α-SMA, while displaying notably diminished levels of E-Cadherin compared to control group. The same findings were observed in PM2.5-treated cells. In BEAS-2B cells co-treated with Stattic (STAT3 inhibitor) and PM2.5, the opposite results occurred. Similar results were obtained for cells co-treated with IL-9-neutralizing antibody and PM2.5. Our findings suggest PM2.5 mediates PF development by promoting IL-9 expression, leading to STAT3 phosphorylation and upregulation of Snail and TWIST1 expression, triggering EMT occurrence and progression in lung epithelial cells.
- Open Access
- 7 February 2024
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 272, 116068
Hypermethylation of PPARG-encoding gene promoter mediates fine particulate matter-induced pulmonary fibrosis by regulating the HMGB1/NLRP3 axis
- 7 February 2024
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 272, 116068
Open AccessHypermethylation of PPARG-encoding gene promoter mediates fine particulate matter-induced pulmonary fibrosis by regulating the HMGB1/NLRP3 axis
- 19 July 2023
- Published by Wiley in Environmental Toxicology
- Vol. 38 (11) , 2608-2620
A novel mitochondria‐targeting compound exerts therapeutic effects against melanoma by inducing mitochondria‐mediated apoptosis and autophagy in vitro and in vivo
Melanoma is the most invasive skin cancer, with a high mortality rate. However, existing therapeutic drugs have side effects, low reactivity, and lead to drug resistance. As the power source in cells, mitochondria play an important role in the survival of cancer cells and are an important target for tumor therapy. This study aimed to develop a new anti‐melanoma compound that targets mitochondria, evaluate its effect on the proliferation and metastasis of melanoma cells, and explore its mechanism of action. The novel mitochondria‐targeting compound, SCZ0148, was synthesized by modifying the structure of cyanine. Then, A375 and B16 cells were incubated with different concentrations of SCZ0148, and different doses of SCZ0148 were administered to A375 and B16 xenograft zebrafish. The results showed that SCZ0148 targeted mitochondria, had dose‐ and time‐dependent effects on the proliferation of melanoma cell lines, and had no obvious side effects on normal cells. In addition, SCZ0148 induced melanoma cell apoptosis through the reactive oxygen species‐mediated mitochondrial pathway of apoptosis and promoted autophagy. SCZ0148 significantly inhibited the migration of melanoma cells via a matrix metalloprotein 9‐mediated pathway. Similarly, SCZ0148 inhibited melanoma cell proliferation in a concentration‐dependent manner in vivo. In summary, SCZ0148 may be a novel anti‐melanoma compound that targets mitochondria.
- 19 July 2023
- Published by Wiley in Environmental Toxicology
- Vol. 38 (11) , 2608-2620
A novel mitochondria‐targeting compound exerts therapeutic effects against melanoma by inducing mitochondria‐mediated apoptosis and autophagy in vitro and in vivo
Melanoma is the most invasive skin cancer, with a high mortality rate. However, existing therapeutic drugs have side effects, low reactivity, and lead to drug resistance. As the power source in cells, mitochondria play an important role in the survival of cancer cells and are an important target for tumor therapy. This study aimed to develop a new anti‐melanoma compound that targets mitochondria, evaluate its effect on the proliferation and metastasis of melanoma cells, and explore its mechanism of action. The novel mitochondria‐targeting compound, SCZ0148, was synthesized by modifying the structure of cyanine. Then, A375 and B16 cells were incubated with different concentrations of SCZ0148, and different doses of SCZ0148 were administered to A375 and B16 xenograft zebrafish. The results showed that SCZ0148 targeted mitochondria, had dose‐ and time‐dependent effects on the proliferation of melanoma cell lines, and had no obvious side effects on normal cells. In addition, SCZ0148 induced melanoma cell apoptosis through the reactive oxygen species‐mediated mitochondrial pathway of apoptosis and promoted autophagy. SCZ0148 significantly inhibited the migration of melanoma cells via a matrix metalloprotein 9‐mediated pathway. Similarly, SCZ0148 inhibited melanoma cell proliferation in a concentration‐dependent manner in vivo. In summary, SCZ0148 may be a novel anti‐melanoma compound that targets mitochondria.
- 25 October 2022
- Published by Wiley in Environmental Toxicology
- Vol. 38 (2) , 403-414
Vitamin B complex blocks the dust fall PM2.5‐induced acute lung injury through DNA methylation in rats
This study aimed to explore whether vitamin B complex (folic acid, B6, and B12) could avert DNA methylation changes associated with inflammation induced by acute PM2.5 exposure. Sprague‐Dawley rats were administered by gavage with different concentrations of vitamin B complex once a day for 28 days, and then by intratracheal instillation with saline or PM2.5 once every 2 days for three times. Vitamin B continued to be taken during the PM2.5 exposure. Rats were sacrificed 24 h after the last exposure. The results showed that vitamin B complex could block the pathological changes and injury in lungs induced by PM2.5. Meanwhile, vitamin B complex could prevent the abnormal DNA methylation of IL‐4 and IFN‐γ to antagonize the imbalance of IL‐4/IFN‐γ associated with inflammation. It was further found that vitamin B complex could regulate DNA methyltransferases (DNMTs) and increase the S‐adenosylmethionine (SAM)/S‐Adenosyl‐L‐homocysteine (SAH) ratio to reverse the hypomethylation of genomic DNA and the abnormal DNA methylation of IL‐4 and IFN‐γ. In conclusion, vitamin B complex has a protective effect on acute lung injury by attenuating abnormal DNA methylation induced by PM2.5 in rats. This study may provide a new insight into the physiological function of vitamin B to prevent the health effects induced by PM2.5.
- 25 October 2022
- Published by Wiley in Environmental Toxicology
- Vol. 38 (2) , 403-414
Vitamin B complex blocks the dust fall PM2.5‐induced acute lung injury through DNA methylation in rats
This study aimed to explore whether vitamin B complex (folic acid, B6, and B12) could avert DNA methylation changes associated with inflammation induced by acute PM2.5 exposure. Sprague‐Dawley rats were administered by gavage with different concentrations of vitamin B complex once a day for 28 days, and then by intratracheal instillation with saline or PM2.5 once every 2 days for three times. Vitamin B continued to be taken during the PM2.5 exposure. Rats were sacrificed 24 h after the last exposure. The results showed that vitamin B complex could block the pathological changes and injury in lungs induced by PM2.5. Meanwhile, vitamin B complex could prevent the abnormal DNA methylation of IL‐4 and IFN‐γ to antagonize the imbalance of IL‐4/IFN‐γ associated with inflammation. It was further found that vitamin B complex could regulate DNA methyltransferases (DNMTs) and increase the S‐adenosylmethionine (SAM)/S‐Adenosyl‐L‐homocysteine (SAH) ratio to reverse the hypomethylation of genomic DNA and the abnormal DNA methylation of IL‐4 and IFN‐γ. In conclusion, vitamin B complex has a protective effect on acute lung injury by attenuating abnormal DNA methylation induced by PM2.5 in rats. This study may provide a new insight into the physiological function of vitamin B to prevent the health effects induced by PM2.5.